Published in J Clin Invest on April 01, 1995
Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody. J Exp Med (1996) 1.61
Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis. Immunol Allergy Clin North Am (2009) 1.51
Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J Exp Med (1997) 1.44
Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. J Clin Invest (1997) 1.33
In vivo neutralization of eosinophil-derived major basic protein inhibits antigen-induced bronchial hyperreactivity in sensitized guinea pigs. J Clin Invest (1996) 0.98
Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways. J Clin Invest (1995) 0.96
Re-defining the unique roles for eosinophils in allergic respiratory inflammation. Clin Exp Allergy (2014) 0.91
Mechanisms of eosinophil major basic protein-induced hyperexcitability of vagal pulmonary chemosensitive neurons. Am J Physiol Lung Cell Mol Physiol (2009) 0.89
Coughing precipitated by Bordetella pertussis infection. Lung (2010) 0.87
Hypersensitivity of pulmonary C fibre afferents induced by cationic proteins in the rat. J Physiol (2001) 0.83
Eosinophil granule-derived major basic protein induces IL-8 expression in human intestinal myofibroblasts. Clin Exp Immunol (2000) 0.83
Poly-L-Arginine Acts Synergistically with LPS to Promote the Release of IL-6 and IL-8 via p38/ERK Signaling Pathways in NCI-H292 Cells. Inflammation (2016) 0.80
A comparison of allergen and polycation induced cutaneous responses in the rabbit. Br J Pharmacol (2001) 0.79
Benralizumab: a unique IL-5 inhibitor for severe asthma. J Asthma Allergy (2016) 0.78
Involvement of kinins in hyperresponsiveness induced by platelet activating factor in the human nasal airway. Br J Pharmacol (2000) 0.78
Arginine deficiency augments inflammatory mediator production by airway epithelial cells in vitro. Respir Res (2009) 0.77
Deciphering Asthma Biomarkers with Protein Profiling Technology. Int J Inflam (2015) 0.76
Hyperresponsiveness in the human nasal airway: new targets for the treatment of allergic airway disease. Mediators Inflamm (1999) 0.75
Pharmacology of Bradykinin-Evoked Coughing in Guinea Pigs. J Pharmacol Exp Ther (2016) 0.75
The Biology of Eosinophils and Their Role in Asthma. Front Med (Lausanne) (2017) 0.75
Capsaicin-induced desensitization of airway mucosa to cigarette smoke, mechanical and chemical irritants. Nature (1983) 2.57
Bradykinin stimulates afferent vagal C-fibers in intrapulmonary airways of dogs. J Appl Physiol Respir Environ Exerc Physiol (1980) 2.28
Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. J Clin Invest (1985) 2.16
Kinin formation: mechanisms and role in inflammatory disorders. Annu Rev Immunol (1988) 2.10
Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am Rev Respir Dis (1989) 2.08
Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest (1983) 2.05
High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature (1994) 1.95
Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma. Mayo Clin Proc (1981) 1.85
Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation. Am Rev Respir Dis (1988) 1.84
Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin. N Engl J Med (1993) 1.81
Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects. J Clin Invest (1987) 1.80
Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J Clin Invest (1991) 1.60
Second messengers involved in the mechanism of action of bradykinin in sensory neurons in culture. J Neurosci (1989) 1.57
Bradykinin-induced airway microvascular leakage and bronchoconstriction are mediated via a bradykinin B2 receptor. Am Rev Respir Dis (1990) 1.57
Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest (1985) 1.45
Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. J Immunol (1983) 1.43
Cationic proteins induce airway hyperresponsiveness dependent on charge interactions. Am Rev Respir Dis (1993) 1.33
Enhancement of factor XII dependent reactions by eosinophil cationic protein. Thromb Res (1979) 1.30
The effect of human eosinophil granule major basic protein on airway responsiveness in the rat in vivo. A comparison with polycations. Am Rev Respir Dis (1993) 1.25
Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge. Am Rev Respir Dis (1992) 1.21
Recent developments in the understanding of bradykinin receptors. Life Sci (1992) 1.16
Bradykinin-induced bronchoconstriction in guinea pig in vivo: role of neural mechanisms. J Pharmacol Exp Ther (1990) 1.16
Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. J Allergy Clin Immunol (1990) 1.14
A bradykinin-antagonist blocks antigen-induced airway hyperresponsiveness and inflammation in sheep. Pulm Pharmacol (1990) 0.97
A bradykinin antagonist modifies allergen-induced mediator release and late bronchial responses in sheep. Am Rev Respir Dis (1991) 0.96
Cationic proteins alter smooth muscle function by an epithelium-dependent mechanism. J Appl Physiol (1985) (1993) 0.94
Immunoglobulin E-mediated release of a kininogenase from purified human lung mast cells. Am Rev Respir Dis (1985) 0.93
Identification of human lung mast cell kininogenase as tryptase and relevance of tryptase kininogenase activity. Biochem Pharmacol (1988) 0.93
Concentrations of glandular kallikrein in human nasal secretions increase during experimentally induced allergic rhinitis. J Immunol (1986) 0.91
Plasma kallikrein during experimentally induced allergic rhinitis: role in kinin formation and contribution to TAME-esterase activity in nasal secretions. J Immunol (1986) 0.88
Effect of bradykinin on airway neural responses in vitro. J Appl Physiol (1985) (1992) 0.86
Role of peptidases and NK1 receptors in vascular extravasation induced by bradykinin in rat nasal mucosa. J Appl Physiol (1985) (1993) 0.84
Effect of heparin and warfarin on chronic hypoxic pulmonary hypertension and vascular remodeling in the guinea pig. Am Rev Respir Dis (1989) 0.83
Localization of immunoreactive tissue kallikrein in human trachea. Am J Respir Cell Mol Biol (1993) 0.82
Effect of Hoe 140, a new bradykinin receptor antagonist, on bradykinin- and platelet-activating factor-induced bronchoconstriction and airway microvascular leakage in guinea pig. Eur J Pharmacol (1992) 0.81
Effect of bradykinin on prostaglandin production by human skin fibroblasts in culture. Methods Enzymol (1985) 0.78
Protamine increases the permeability of cultured epithelial monolayers. J Appl Physiol (1985) (1990) 0.78
Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med (2000) 9.44
Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med (1997) 7.12
Reliability and validity of DSM-IV axis V. Am J Psychiatry (2000) 2.59
Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J Exp Med (1997) 2.36
Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J (2007) 2.16
Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest (1995) 2.05
Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest (1983) 2.05
Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet (1987) 1.98
Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse. J Allergy Clin Immunol (1992) 1.95
Purification of human eosinophil-derived neurotoxin. Proc Natl Acad Sci U S A (1981) 1.85
Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med (1985) 1.84
Hyperpolarization-activated chloride currents in Xenopus oocytes. J Gen Physiol (1994) 1.80
Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects. J Clin Invest (1987) 1.80
Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. N Engl J Med (1985) 1.79
Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med (1983) 1.69
Expression of mRNA for the GATA-binding proteins in human eosinophils and basophils: potential role in gene transcription. Blood (1993) 1.68
Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc Natl Acad Sci U S A (1986) 1.67
Development of eosinophilic airway inflammation and airway hyperresponsiveness requires interleukin-5 but not immunoglobulin E or B lymphocytes. Am J Respir Cell Mol Biol (1999) 1.64
The detection of collapsible airways contributing to airflow limitation. Chest (1995) 1.62
Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. JAMA (2000) 1.62
Subtle orthopedic fractures: teleradiology workstation versus film interpretation. Radiology (1993) 1.57
The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. J Clin Invest (1999) 1.56
Increased lower airways responsiveness associated with sinusitis in a rabbit model. Am Rev Respir Dis (1993) 1.54
Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2001) 1.53
Hard-rock mining exposures affect smokers and nonsmokers differently. Results of a community prevalence study. Am Rev Respir Dis (1989) 1.52
New insights from lung function. Curr Opin Allergy Clin Immunol (2001) 1.52
Antigen-specific IgE and IgA antibodies in bronchoalveolar lavage fluid are associated with stronger antigen-induced late phase reactions. Clin Exp Allergy (2001) 1.46
Influence of sleep on lung volume in asthmatic patients and normal subjects. J Appl Physiol (1985) (1990) 1.45
Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest (1985) 1.45
Kinins are generated during experimental rhinovirus colds. J Infect Dis (1988) 1.44
Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. J Immunol (1983) 1.43
Unitary anion currents through phospholemman channel molecules. Nature (1995) 1.43
Strain dependence of airway hyperresponsiveness reflects differences in eosinophil localization in the lung. Am J Physiol Lung Cell Mol Physiol (2001) 1.43
Cyclooxygenase metabolism of endogenous arachidonic acid by cultured human tracheal epithelial cells. Am Rev Respir Dis (1989) 1.41
The invaluable pressure-volume curve. Chest (2000) 1.41
Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. Am Rev Respir Dis (1990) 1.40
Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes. Am Rev Respir Dis (1991) 1.38
Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity. J Allergy Clin Immunol (1991) 1.37
Molecular cloning of the human eosinophil-derived neurotoxin: a member of the ribonuclease gene family. Proc Natl Acad Sci U S A (1989) 1.35
Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins. J Immunol (1984) 1.35
Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial. Transfusion (1999) 1.34
Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. J Immunol (1995) 1.33
Cationic proteins induce airway hyperresponsiveness dependent on charge interactions. Am Rev Respir Dis (1993) 1.33
Increased numbers of hypodense eosinophils in the blood of patients with bronchial asthma. Am Rev Respir Dis (1985) 1.32
Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. J Immunol (1987) 1.32
Formation of Charcot-Leyden crystals by human basophils. J Exp Med (1982) 1.30
Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni. Am J Trop Med Hyg (1985) 1.29
Human eosinophil cationic protein. Molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity. J Exp Med (1989) 1.29
Identification of a chymotrypsin-like proteinase in human mast cells. J Immunol (1986) 1.29
Increases in airway reactivity to histamine and inflammatory cells in bronchoalveolar lavage after the late asthmatic response in an animal model. Am Rev Respir Dis (1985) 1.28
Adverse effects of phenobarbital on corticosteroid metabolism in patients with bronchial asthma. N Engl J Med (1972) 1.27
Upper respiratory tract environmental tobacco smoke sensitivity. Am Rev Respir Dis (1991) 1.27
Heterogeneity of human peripheral blood eosinophil-type colonies: evidence for a common basophil-eosinophil progenitor. Blood (1985) 1.27
Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J Virol (1998) 1.26
An immunofluorescent method for specific staining of eosinophil granule major basic protein. J Immunol Methods (1981) 1.26
The effect of human eosinophil granule major basic protein on airway responsiveness in the rat in vivo. A comparison with polycations. Am Rev Respir Dis (1993) 1.25
The requirement for polymorphonuclear leukocytes in the late asthmatic response and heightened airways reactivity in an animal model. Am Rev Respir Dis (1986) 1.22
Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge. Am Rev Respir Dis (1992) 1.21
Characterization of vagal afferent subtypes stimulated by bradykinin in guinea pig trachea. J Pharmacol Exp Ther (1999) 1.20
Combinatorial splicing of exon pairs by two-site binding of U1 small nuclear ribonucleoprotein particle. Mol Cell Biol (1991) 1.19
Bradykinin antagonists. Annu Rev Pharmacol Toxicol (1991) 1.19
Destruction of bloodstream forms of Trypanosoma cruzi by eosinophil granule major basic protein. Am J Trop Med Hyg (1981) 1.17
The human eosinophil Charcot-Leyden crystal protein: biochemical characteristics and measurement by radioimmunoassay. J Immunol (1980) 1.17
Localization of eosinophil granule major basic protein in human basophils. J Exp Med (1983) 1.16
Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells. Immunology (1992) 1.14
Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide. J Immunol (1999) 1.14
Changes in bronchial responsiveness following nasal provocation with allergen. J Allergy Clin Immunol (1992) 1.12
Epithelia cells as regulators of airway inflammation. J Allergy Clin Immunol (1998) 1.12
Calcium ionophore A23187 calcium-dependent cytolytic degranulation in human eosinophils. J Immunol (1985) 1.12
Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. J Clin Invest (1985) 1.11
Effects of cool, dry air stimulation on peripheral lung mechanics in asthma. Am J Respir Crit Care Med (2000) 1.11
Eosinophil-fibroblast interactions. Granule major basic protein interacts with IL-1 and transforming growth factor-beta in the stimulation of lung fibroblast IL-6-type cytokine production. J Immunol (1996) 1.10
In vivo release of inflammatory mediators by hyperosmolar solutions. Am Rev Respir Dis (1988) 1.08
Cytoplasmic lipid bodies of human neutrophilic leukocytes. Am J Pathol (1989) 1.08
Eosinophil granule major basic protein and Charcot-Leyden crystal protein in human tears. Am J Ophthalmol (1981) 1.08
Forced GATA-1 expression in the murine myeloid cell line M1: induction of c-Mpl expression and megakaryocytic/erythroid differentiation. Blood (1998) 1.08
Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol (1992) 1.05
Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors. J Immunol (1986) 1.05
Induction of interleukin-4-dependent IgE synthesis and interleukin-5-dependent eosinophil differentiation by supernatants of a human helper T-cell clone. J Clin Immunol (1988) 1.04
An alternative method for labeling oligonucleotide probes for screening cDNA libraries. Biotechniques (1990) 1.03
Cytoplasmic lipid bodies of neutrophils: formation induced by cis-unsaturated fatty acids and mediated by protein kinase C. J Cell Biol (1991) 1.02
Cigarette smoke modulates rhinovirus-induced airway epithelial cell chemokine production. Eur Respir J (2009) 1.02
Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects. J Allergy Clin Immunol (2001) 1.00
Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology. Am J Respir Crit Care Med (1996) 1.00
Human lung macrophages induce histamine release from basophils and mast cells. Am Rev Respir Dis (1985) 1.00
Characterization and localization of human renal kininogen. J Biol Chem (1981) 1.00
CD23 exhibits negative regulatory effects on allergic sensitization and airway hyperresponsiveness. Am J Respir Crit Care Med (2000) 0.99
Influx of kininogens into nasal secretions after antigen challenge of allergic individuals. J Clin Invest (1985) 0.99
Distal lung dysfunction at night in nocturnal asthma. Am J Respir Crit Care Med (2001) 0.99
Detection and partial characterization of a human mast cell carboxypeptidase. J Immunol (1987) 0.99
Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils, and extracellular matrix of the skin in the hypereosinophilic syndrome. Lab Invest (1990) 0.99
Seattle YouthCare's prevention, intervention, and education program: a model of care for HIV-positive, homeless, and at-risk youth. J Adolesc Health (1998) 0.98
Effect of intranasal capsaicin on symptoms and mediator release. J Pharmacol Exp Ther (1991) 0.98
Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med (1987) 0.98
Anion, cation, and zwitterion selectivity of phospholemman channel molecules. Biophys J (1997) 0.98
Human lung macrophages enhance and inhibit lymphocyte proliferation. J Immunol (1984) 0.98